Krebs Biochemicals & Industries board nods allotment of Rs100cr RNNCPS to IPCA Labs

  • India Infoline News Service |
  • 30 Dec, 2021 |
  • 3:21 PM
Stock Market Trader, Stock Trader, Trading
Krebs Biochemicals & Industries Ltd has informed to the Exchange that the Board of Directors at its meeting held on Thursday, December 30, 2021 has approved the allotment of 1,00,00,000, Redeemable Non-Convertible Non-Cumulative Preference Shares (RNNCPS) of Rs100/ each aggregating to Rs100cr, on private placement basis to IPCA Laboratories Limited, a promoter group company.

At around 3:20 PM, Krebs Biochemicals & Industries was trading at Rs193.90 apiece up by Rs32.3 or 19.99% from its previous closing of Rs161.60 apiece on the BSE.

Invest wise with Expert advice

ad IconAd Image

Most Read News

Article Image
  • 14 March, 2022 |
  • 7:03 AM

The US Federal committee's meeting will conclude on March 16, 2022.

Most Shared News

No Record Found